Cerebral toxoplasmosis mimicking subacute meningitis in HIV-infected patients; a cohort study from Indonesia

PLoS Negl Trop Dis. 2013;7(1):e1994. doi: 10.1371/journal.pntd.0001994. Epub 2013 Jan 10.

Abstract

Background: HIV-associated subacute meningitis is mostly caused by tuberculosis or cryptococcosis, but often no etiology can be established. In the absence of CT or MRI of the brain, toxoplasmosis is generally not considered as part of the differential diagnosis.

Methodology/principal findings: We performed cerebrospinal fluid real time PCR and serological testing for Toxoplasma gondii in archived samples from a well-characterized cohort of 64 HIV-infected patients presenting with subacute meningitis in a referral hospital in Indonesia. Neuroradiology was only available for 6 patients. At time of presentation, patients mostly had newly diagnosed and advanced HIV infection (median CD4 count 22 cells/mL), with only 17.2% taking ART, and 9.4% PJP-prophylaxis. CSF PCR for T. Gondii was positive in 21 patients (32.8%). Circulating toxoplasma IgG was present in 77.2% of patients tested, including all in whom the PCR of CSF was positive for T. Gondii. Clinically, in the absence of neuroradiology, toxoplasmosis was difficult to distinguish from tuberculosis or cryptococcal meningitis, although CSF abnormalities were less pronounced. Mortality among patients with a positive CSF T. Gondii PCR was 81%, 2.16-fold higher (95% CI 1.04-4.47) compared to those with a negative PCR.

Conclusions/significance: Toxoplasmosis should be considered in HIV-infected patients with clinically suspected subacute meningitis in settings where neuroradiology is not available.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Protozoan / blood
  • Cerebrospinal Fluid / parasitology
  • Cohort Studies
  • Diagnosis, Differential
  • Female
  • HIV Infections / complications*
  • Humans
  • Immunoglobulin G / blood
  • Indonesia
  • Male
  • Meningitis / diagnosis*
  • Meningitis / pathology*
  • Polymerase Chain Reaction
  • Survival Analysis
  • Toxoplasma / isolation & purification*
  • Toxoplasma / pathogenicity
  • Toxoplasmosis, Cerebral / diagnosis*
  • Toxoplasmosis, Cerebral / pathology*

Substances

  • Antibodies, Protozoan
  • Immunoglobulin G

Grants and funding

This study was financially supported by the Royal Academy of Arts and Sciences (KNAW, www.knaw.nl; 07-MP-10), the Netherlands; and by IMPACT, a 5-year HIV program supported by the European Commission (SANTE/2005/105-033). Ahmad Rizal Ganiem, Lidya Chaidir and Rudi Wisaksana are supported by fellowships from Radboud University Nijmegen Medical Center. Reinout van Crevel has a VIDI-grant from the Netherlands Organization for Scientific Research (NWO, www.nwo.nl; 017.106.310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.